• Tecentriq-Cotellic Combo Fails to Lengthen Survival in Advanced Colorectal Cancer
  • Phase 1 Trial on Treos’ Potential Colorectal Cancer Vaccine Doses First Patient
  • Eli Lilly Acquires Pegilodecakin, Potential Immunotherapy Now in Phase 3 Trial
  • Humanized CAR T-cell Therapy Seen to Treat Metastatic Colorectal Cancer in Mouse Study
  • FDA Grants Priority Review to Tecentriq Combo for First-Line Treatment of Advanced Lung Cancer
  • Canada Approves Imfinzi for Advanced, Inoperable Non-small Cell Lung Cancer
  • Researchers May Now Predict Which CLL Patients Will Respond to Kymriah CAR T-Cell Therapy, Study Says
  • Study Evaluating VBI-1901 Enrolling Recurrent GBM Patients in Second Dose Group
  • Advanced Melanoma Patients Seen to Respond to CMP-001, Keytruda Combo in Ongoing Study
  • EMA to Review Keytruda Combo as First-line Treatment for Advanced NSCLC Patients in EU
  • New Combo Treatment for Advanced Solid Tumors is Goal of Partnership
  • Once Monthly Opdivo Use Approved in EU for Certain Melanoma, Renal Cell Cancer Patients